Evidence map›Paper›PMID 39290519›Full record

ArticleContemporary clinical trials communications2024

A multicomponent smoking cessation program for adults with Type 2 Diabetes Mellitus (

Carla López-Núñez, Sergio Fernández-Artamendi, Desirée Ruiz-Aranda, Davinia María Resurrección, Desirée Navas-Campaña

Registry-linked trialAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Contemporary clinical trials communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05885659 (A Multicomponent Smoking Cessation Program for Adults With Type 2 Diabetes Mellitus), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05885659 naunknown statusnot on this map

A Multicomponent Smoking Cessation Program for Adults With Type 2 Diabetes Mellitus: A Study Protocol of a Randomized Controlled Trial (DiMe-SALUD2 Project)

TypeinterventionalSponsorUniversity of SevilleRan2023 to 2025Enrolled90ConditionsTobacco Use Disorder, Diabetes Mellitus, Type 2ArmsControl group (waiting list), Cognitive Behavioral Treatment (CBT) for smoking cessation, CBT for smoking cessation + DiMeSALUD2 protocol
3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Carla López-NúñezDepartment of Personality, Assessment and Psychological Treatments, School of Psychology, University of Seville, Seville (Andalusia), Spain.
Sergio Fernández-ArtamendiDepartment of Personality, Assessment and Psychological Treatments, School of Psychology, University of Seville, Seville (Andalusia), Spain.
Desirée Ruiz-ArandaDepartment of Psychology, Universidad Loyola Andalucía, Seville (Andalusia), Spain.
Davinia María ResurrecciónDepartment of Psychology, Universidad Loyola Andalucía, Seville (Andalusia), Spain.
Desirée Navas-CampañaDepartment of Psychology, Universidad Loyola Andalucía, Seville (Andalusia), Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Tobacco use represents a significant public health burden, being especially harmful for smokers with Type 2 Diabetes Mellitus (T2DM). Effective smoking cessation interventions are required for this vulnerable population. The goal is to describe a study protocol of a randomized controlled trial (RCT) aimed at analyzing the effectiveness and efficiency of a multicomponent smoking cessation intervention for T2DM smokers, including a training protocol on healthy lifestyle habits and self-management of T2DM ( Methods: This RCT will assign participants to: (1) Control Group (n = 30), including a brief psychoeducation advice about smoking cessation; (2) Cognitive-behavioral treatment (CBT) for smoking cessation (n = 30), based on a multicomponent program implemented in group-based sessions over an eight-week period; and (3) CBT plus Discussion: The Trial registration: ClinicalTrials.gov. Identifier: NCT05885659. Date of registration: June 2nd, 2023.

Indexed as

AdultsProtocol studyPsychological treatmentSmoking cessationType 2 diabetes mellitus (T2DM)

Identifiers

PMID39290519
PMCPMC11405626

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.